Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies ConferenceIain C. Macdougall, Elena Zakharova, Yusuke Tsukamoto et al.|Kidney International|2016Cited by 474
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patientsJürgen Floege, Adrian Covic, Markus Ketteler et al.|Nephrology Dialysis Transplantation|2015Cited by 142